About Journal of Epidemiology

About Journal of Epidemiology

Aims and Scope

The Journal of Epidemiology is the official open access scientific journal of the Japan Epidemiological Association. The Journal publishes a broad range of original research on epidemiology as it relates to human health, and aims to promote communication among those engaged in the field of epidemiological research and those who use epidemiological findings.

Open Access License Policy

creative commons

The Journal of Epidemiology applies the Creative Commons Attribution 3.0 Unported License (CC-BY License) to all works we publish (read the human-readable summary or the full license legal code) on April 1, 2013. Under the terms of the CC-BY License, authors retain ownership of the copyright for their work but must allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in the Journal of Epidemiology, as long as the original authors and source are properly credited.
No further permission is required from the authors or publisher.

In most cases, appropriate attribution can be provided by simply citing the original article and providing the license terms, as in the following
example:
Fujino, Yoshihisa et al. (2013) Taxation Categories for Long-term Care Insurance Premiums and Mortality Among Elderly Japanese: A Cohort Study. Journal of Epidemiology 23(1):41-46 doi:10.2188/jea.JE20120011, licensed under Creative Commons Attribution 3.0 Unported License.

If an item you plan to reuse is not part of a published article (e.g., an item created by a third party and quoted in the article), it should not be considered licensed for reuse under the CC-BY license unless otherwise noted. In such cases, you can only reuse an item under copyright exceptions such as fair use or quotation, except as stated in the applicable copyright law or any license terms indicated in the original work in which the item appeared. The CC-BY license was developed to facilitate open access to and free use of original works of all types. Applying this standard license to a work will ensure that it is freely and openly available.

Publication Fee

All submissions on or after June 1, 2016 that are accepted for publication

70,000 JPY per article (for JEA members)
120,000 JPY per article (for nonmembers)
・Members and non-members alike will be charged 10,000 JPY per page when the article exceeds 8 pages.
・Publication of Letters will cost 10,000 JPY per Letter notwithstanding membership. There are no charges for responses to Letters.
・Publication of Erratum will cost 10,000 JPY per page notwithstanding membership.
・Submissions from Japan require that both first author and corresponding author are members of JEA for the membership price to be applicable.
・Submissions from other countries will be charged the membership price if the first author is a member of the JEA.
・Submissions from Japan and other countries require that both first author and corresponding author must be members of JEA to be charged the membership price.
・Authors must be a member at time of submission for the membership price to be applicable.


This journal does not charge submission charges.

  1st author Outside Japan nonmember Corresponding author Outside Japan nonmember
1st author in Japan member - nonmember fee
Corresponding author in Japan member nonmember fee -
1st author Outside Japan member - member fee
Corresponding author Outside Japan member nonmember fee -

Editorial Board

Editor-in-Chief Keitaro Matsuo Aichi Cancer Center Research Institute, Nagoya, Japan
Deputy Editor Kota Katanoda National Cancer Center, Tokyo, Japan
Deputy Editor Takeo Fujiwara Tokyo Medical and Dental University (TMDU), Tokyo, Japan
Consulting Editors Manami Inoue National Cancer Center, Tokyo, Japan
Associate Editors Jun Aida Tohoku University, Sendai, Japan
Hisatomi Arima Fukuoka University, Fukuoka, Japan
Keiko Asao Eli Lilly Japan, K.K., Tokyo, Japan
Wanqing Chen Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
Wakaba Fukushima Osaka City University, Osaka, Japan
Silvano Gallus Istituto di Ricerche Farmacologiche Mario Negri, Italy
Aya Goto Fukushima Medical University, Fukushima, Japan
Atsushi Goto National Cancer Center, Tokyo, Japan
Megumi Hara Saga University, Saga, Japan
Kenshi Hayashida University of Occupational and Envoronmental Health, Kitakyushu, Japan
Kaori Honjo Osaka University, Suita, Osaka, Japan
Atsushi Hozawa Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan
Tatsuro Ishizaki Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Hidemi Ito Aichi Cancer Center Research Institute, Nagoya, Japan
Satoshi Kaneko Nagasaki University, Nagasaki, Japan
Jeongseon Kim National Cancer Center, Seoul, The Republic of Korea
Naoki Kondo The University of Tokyo, Tokyo, Japan
Hiroshi Maruyama The University of Tokyo, Tokyo, Japan
Yoshitaka Murakami Toho University, Tokyo, Japan
Mariko Naito Nagoya University, Nagoya, Japan
Koshi Nakamura Hokkaido University, Sapporo, Japan
Yuji Nishiwaki Toho University, Tokyo, Japan
Takeshi Nishiyama Aichi Medical University, Nagakute, Aichi, Japan
Tetsuya Ohira Fukushima Medical University, Fukushima, Japan
Yasuyuki Okumura Institute for Health Economics and Policy, Tokyo, Japan
Shizuka Sasazuki National Cancer Center, Tokyo, Japan
Susumu Sawada National Institute of Biomedical Innovation, Tokyo, Japan
Aesun Shin Seoul National University, Korea
Derek Smith James Cook University, Townsville, Australia
Kohta Suzuki Aichi Medical University, Nagakute, Aichi, Japan
Sadao Suzuki Nagoya City University, Nagoya, Japan
Satoshi Teramukai Kyoto Prefectural University of Medicine, Kyoto, Japan
Kevin Urayama St. Luke's International University, Tokyo, Japan
Rob van Dam National University of Singapore, Singapore
Koji Wada National Center for Global Health and Medicine, Tokyo, Japan
Kenji Wakai Nagoya University, Nagoya, Japan
Peiyu Wang Peking University, Beijing, China
Kazumasa Yamagishi University of Tsukuba, Tsukuba, Japan
Hideo Yasunaga The University of Tokyo, Tokyo, Japan
Hiroshi Yatsuya Fujita Health University, Toyoake, Japan
Takashi Yorifuji Okayama University, Okayama, Japan
International Advisory Board
Robert Abbott Radiation Effects Research Foundation, Hiroshima, Japan
Chang-Chuan Chan College of Public Health, National Taiwan University, Taipei, Taiwan
Paulo Chaves Benjamin Leon Center for Geriatric Research and Education, Florida International University, Miami, USA
Sin Eng Chia National University of Singapore, Singapore
Aaron Folsom University of Minnesota, Minneapolis, USA
Graham Giles Cancer Council Victoria, Australia
Yue-Liang Leon Guo College of Public Health, National Taiwan University and NTU Hospital, Taipei, Taiwan
Chung-Cheng Hsieh University of Massachusetts, Cancer Center, Worcester, USA
David Jacobs University of Minnesota, Minneapolis, USA
Daehee Kang Seoul National University, Seoul, Korea
Ichiro Kawachi Harvard School of Public Health, Boston, USA
Eero Lahelma University of Helsinki, Finland
Yunhwan Lee Ajou University School of Medicine, Suwon, Korea
Jersey Liang Shool of Public Health, University of Michigan, Ann Arbor, USA
Michael Marmot University College London, London, UK
You-Lin Qiao Cancer Institute / Hospital, Chinese Academy of Medical Sciences, Beijing, China
Hai Rim Shin International Agency for Research on Cancer, Lyon, France
Suraporn Wiangnon Khon Kaen University, Faculty of Medicine, Khon Kaen, Thailand
Editorial Staff Kaoru Yoshida Japan Epidemiological Association, Tokyo, Japan
Editorial Assistant Tamami Kitamura Japan Epidemiological Association, Tokyo, Japan
Mikiko Muto Japan Epidemiological Association, Tokyo, Japan